Medical Chemistry

Research Frontiers in Src Family Kinase Inhibitor Selectivity and Optimization

Development of selective Src, Lyn, and Fyn inhibitors with improved kinase selectivity profiles for chronic myelogenous leukemia and bone diseases.

All Medical Chemistry PhD categories